The impact of funding cuts on medical research can hardly be overstated, particularly as recent federal budgetary decisions cast shadows over critical initiatives aimed at patient safety in research.These cuts threaten to disrupt the delicate balance that ensures ethical oversight and participant well-being, as the loss of billions in medical research funding stifles innovation and reduces the capacity for clinical trials.